Showing results (1421-1430 of 1,484) with videos related to

Sort By:
Pageof 149
Haematologica|January 29, 2026
GVHD and GRFS in patients with acute myeloid leukemia undergoing allogeneic HCT with treosulfan- versus reduced-intensity busulfan-based conditioning: a subgroup analysis of a randomized phase 3 trialFriedrich Stölzel, Matthias Stelljes, Dietrich Wilhelm Beelen, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|November 2, 2022
Conditioning Regimens are Associated with Distinct Patterns of Microbiota Injury in Allogeneic Hematopoietic Cell TransplantationRoni Shouval, Nicholas R Waters, Antonio L C Gomes, et al.
Blood Advances|July 1, 2025
Refinement of Day 28 Treatment Response Criteria for Acute GVHD: A Collaboration Study of the JSTCT and MAGICYu Akahoshi, Yoshihiro Inamoto, Nikolaos Spyrou, et al.
Clinical Immunology (Orlando, Fla.)|August 8, 2024
Deep immune cell phenotyping and induced immune cell responses at admission stratified by BMI in patients hospitalized with COVID-19: An observational multicenter cohort pilot studyAdin Sejdic, Hans Jakob Hartling, Jon Gitz Holler, et al.
Transplantation and Cellular Therapy|December 12, 2024
Serial Clinical and Biomarker Monitoring during Graft-Versus-Host Disease Treatment Identifies Distinct Risk Strata Including an Ultra-Low Risk GroupNikolaos Katsivelos, Nikolaos Spyrou, Daniela Weber, et al.
American Journal of Hematology|May 26, 2022
Treosulfan compared with reduced-intensity busulfan improves allogeneic hematopoietic cell transplantation outcomes of older acute myeloid leukemia and myelodysplastic syndrome patients: Final analysis of a prospective randomized trialDietrich W Beelen, Matthias Stelljes, Péter Reményi, et al.
Eclinicalmedicine|September 1, 2023
Pooled allogeneic faecal microbiota MaaT013 for steroid-resistant gastrointestinal acute graft-versus-host disease: a single-arm, multicentre phase 2 trialFlorent Malard, Michael Loschi, Anne Huynh, et al.
Blood Advances|December 22, 2020
Biomarker-guided preemption of steroid-refractory graft-versus-host disease with α-1-antitrypsinStephanie C Gergoudis, Zachariah DeFilipp, Umut Özbek, et al.
Nature|October 24, 2024
Rifaximin prophylaxis causes resistance to the last-resort antibiotic daptomycinAdrianna M Turner, Lucy Li, Ian R Monk, et al.
Cancer Research|January 20, 2019
Blockade of a Laminin-411-Notch Axis with CRISPR/Cas9 or a Nanobioconjugate Inhibits Glioblastoma Growth through Tumor-Microenvironment Cross-talkTao Sun, Rameshwar Patil, Anna Galstyan, et al.
Pageof 149